Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for Lithium Response in Bipolar Disorder
NCT02909504Phase 4Terminated
- Sponsor
- Keming Gao
- Start
- Sep 2016
- Primary completion
- Nov 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium in bipolar disorder (BD), sponsored by Keming Gao. Started Sep 2016; status: terminated.
02
Drugs
lithium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02909504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909504.